DalsnaFinance Account

GE HealthCare $GEHC

Health Care · Health Care Equipment · NASDAQ

S&P 500 Nasdaq-100 Russell 1000 Illinois

Create a scorecard

$70.34

+0.58 (+0.83%)

As of Oct 20, 2026, 12:08 PM EDT · cached

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 5, 2026, the first target we tracked for GEHC.

Key facts

52-week range (closes): $59.49 – $88.16 Lowest close Apr 29, 2026, highest Jan 8, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Next earnings: Oct 28, 2026, before the open · EPS forecast $1.21 Nasdaq earnings calendar, as of Oct 20, 2026
Fiscal year ends: December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since: Jan 4, 2023 · General Electric completed the corporate spin-off of GE HealthCare. · All S&P 500 changes
In the Nasdaq-100 since: Jun 7, 2023, replacing Fiserv (FI) · Fiserv transferred its listing from NASDAQ to the NYSE. · All Nasdaq-100 changes
Analyst coverage: 2 open price targets from 2 firms: Needham, RBC Capital Markets Approved targets tracked here; see the analyst section below

GE HealthCare (GEHC) is trading up at $70.34 (+0.83%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Analyst price targets on GEHC

Current price targets from 2 firms average $86.5, ranging from $80 to $93 — 23% above the current $70.3. Each is tracked to its date and scored the same way a member's call is.

Needham $65.1 → $93 by Oct 2027 Buy Oct 5, 2026 via Investing.com · Needham's track record
RBC Capital Markets $65.1 → $80 by Oct 2027 Outperform Oct 5, 2026 via Investing.com · RBC Capital Markets's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

GE HealthCare revenue & net income history (FY2021–FY2025)

RevenueNet incomeNet margin (right axis, %)

GE HealthCare annual financial statements
	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
Growth (year over year)	—	+4.3%	+6.6%	+0.6%	+4.8%
Gross profit	$7.17B	$7.18B	$7.92B	$8.21B	$8.25B
Gross margin	40.8%	39.1%	40.5%	41.7%	40.0%
Operating income	$2.79B	$2.52B	$2.44B	$2.63B	$2.76B
Operating margin	15.9%	13.8%	12.5%	13.3%	13.4%
Net income	$2.25B	$1.92B	$1.57B	$1.99B	$2.08B
Net margin	12.8%	10.4%	8.0%	10.1%	10.1%
EPS (diluted)	$4.95	$4.22	$3.03	$4.34	$4.55
Balance sheet
Cash and equivalents	$561.0M	$1.44B	$2.49B	$2.87B	$4.49B
Total assets	—	$27.5B	$32.5B	$33.1B	$36.9B
Total liabilities	—	$17.9B	$25.1B	$24.4B	$26.3B
Long-term debt	—	$8.23B	$8.44B	$7.45B	$9.49B
Shareholders' equity	$16.7B	$9.36B	$7.13B	$8.45B	$10.4B
Cash flow
Operating cash flow	$1.61B	$2.13B	$2.10B	$1.96B	$1.99B
Capital expenditure	$248.0M	$310.0M	$387.0M	$401.0M	$482.0M
Free cash flow	$1.36B	$1.82B	$1.71B	$1.55B	$1.50B
Dividends paid	$0	$0	$41.0M	$55.0M	$64.0M
Share buybacks	—	—	$0	$0	$200.0M

RevenueNet incomeNet margin (right axis, %)

GE HealthCare quarterly financial statements
	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026
Income statement
Revenue	$4.84B	$4.86B	$5.32B	$4.78B	$5.01B	$5.14B	$5.70B	$5.13B
Growth (year over year)	+0.5%	+0.9%	+2.2%	+2.7%	+3.5%	+5.8%	+7.1%	+7.4%
Gross profit	$2.00B	$2.03B	$2.27B	$2.01B	$1.99B	$1.99B	$2.26B	$1.98B
Gross margin	41.4%	41.7%	42.8%	42.1%	39.6%	38.7%	39.7%	38.5%
Operating income	$608.0M	$676.0M	$801.0M	$629.0M	$654.0M	$653.0M	$827.0M	$515.0M
Operating margin	12.6%	13.9%	15.1%	13.2%	13.1%	12.7%	14.5%	10.0%
Net income	$428.0M	$470.0M	$721.0M	$564.0M	$486.0M	$446.0M	$588.0M	$389.0M
Net margin	8.8%	9.7%	13.6%	11.8%	9.7%	8.7%	10.3%	7.6%
EPS (diluted)	$0.93	$1.02	$1.58	$1.23	$1.06	$0.98	$1.28	$0.85
Balance sheet
Cash and equivalents	$2.00B	$3.55B	$2.87B	$2.45B	$3.74B	$4.00B	$4.49B	$2.26B
Total assets	$31.9B	$33.9B	$33.1B	$33.6B	$35.5B	$36.1B	$36.9B	$37.1B
Total liabilities	$23.9B	$25.3B	$24.4B	$24.2B	$25.5B	$25.9B	$26.3B	$26.2B
Long-term debt	$8.23B	$9.31B	$7.45B	$6.76B	$8.27B	$8.28B	$9.49B	$10.1B
Shareholders' equity	$7.80B	$8.32B	$8.45B	$9.19B	$9.71B	$9.99B	$10.4B	$10.7B
Cash flow
Operating cash flow	−$119.0M	$742.0M	$913.0M	$250.0M	$94.0M	$593.0M	$1.05B	$290.0M
Capital expenditure	$64.0M	$90.0M	$102.0M	$152.0M	$86.0M	$110.0M	$134.0M	$178.0M
Free cash flow	−$183.0M	$652.0M	$811.0M	$98.0M	$8.00M	$483.0M	$916.0M	$112.0M
Dividends paid	$14.0M	$13.0M	$14.0M	$16.0M	$16.0M	$16.0M	$16.0M	$16.0M
Share buybacks	—	$0	$0	$0	$100.0M	$100.0M	$0	$100.0M

From GE HealthCare's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

GE HealthCare vs the Health Care sector and the S&P 500

GE HealthCare's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

GE HealthCare compared with the median Health Care company and the median S&P 500 company
Measure	GE HealthCare	Health Care (59 other S&P 500 companies)	S&P 500 (502 other companies)
Revenue growth, latest fiscal year	+4.8%	+7.2%	+7.0%
Net margin, latest fiscal year	10.1%	13.1%	13.0%
Dividend per share, latest fiscal year	$0.14	$2.48	$2.40
Share price change, 1 year	−7.6%	+19.8%	+5.9%

GE HealthCare: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, GE HealthCare included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About GE HealthCare

GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.

Source: Wikipedia — GE HealthCare